Inspira Technologies Oxy B.H.N. Ltd. (IINN)
Market Cap | 17.40M |
Revenue (ttm) | n/a |
Net Income (ttm) | 19.60M |
Shares Out | 11.70M |
EPS (ttm) | -1.13 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 779 |
Open | 1.40 |
Previous Close | 1.38 |
Day's Range | 1.35 - 1.48 |
52-Week Range | 0.98 - 1.99 |
Beta | 2.30 |
Analysts | Strong Buy |
Price Target | 13.00 (+841.69%) |
Earnings Date | Nov 22, 2023 |
About IINN
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabi... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for IINN stock is "Strong Buy" and the 12-month stock price forecast is $13.0.
News

Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization
Management estimates FDA clearance within approximately 6 months RA'ANANA, Israel , Sept. 13, 2023 /PRNewswire/ -- Inspira™ Technologies OXY BHN Ltd.

Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
The extended agreement covers any European country RA'ANANA, Israel , Aug. 29, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a...

Inspira™ Technologies Reports Second Quarter 2023 Financial Results
As of June 30, 2023, the Company had $8.9 million in cash, cash equivalents and short-term bank deposits. RA'ANANA, Israel , Aug. 10, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
RA'ANANA, Israel , Aug. 9, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute ...

Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
RA'ANANA, Israel , July 24, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respirat...

Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
Perfusion Solution, Inc. is a leading U.S.-based company that provides a platform of advanced medical devices, training and staffing to leading U.S. hospitals. RA'ANANA, Israel , July 19, 2023 /PRNews...

Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
RA'ANANA, Israel , June 15, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute...

Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
Dr. Nir is a clinical strategy expert with market experience RA'ANANA, Israel , May 30, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Insp...

Inspira™ Technologies Reports First Quarter 2023 Financial Results
As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits RA'ANANA, Israel , May 18, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq...

Inspira™ Technologies will Reveal the New ALICE™ Device at the World's Largest Extracorporeal Life Support Conference
The ELSO conference is a consortium of healthcare institutions, researchers, and industry partners RA'ANANA, Israel , May 16, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ...

Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
Total addressable market is currently estimated at $1.16 billion RA'ANANA, Israel , May 11, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or ...

Inspira Technologies and Genius Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / May 5, 2023 / RedChip Companies will air new interviews with Inspira Technologies OXY B.H.N. Ltd. (Nasdaq:IINN, IINNW) and Genius Group Limited (NYSE American:GNS) on The Re...

Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas
RA'ANANA, ISRAEL / ACCESSWIRE / April 24, 2023 / Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)(NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute re...

Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
As of December 31, 2022, the Company had $13.9 million in cash, cash equivalents, and deposits. RA'ANANA, Israel , April 4, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
First use of HYLA in a patient undergoing open-heart surgery at Sheba Medical Center in Israel RA'ANANA, Israel , March 22, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (...

Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
The clinical study is planned for Q1-2023 to be performed on patients undergoing open-heart surgery at Sheba Medical Center RA'ANANA, Israel , Feb. 13, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B...

Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
All 20 claims were found to be novel, with inventive step and industrial applicability RA'ANANA, Israel , Jan. 23, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: II...

Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
Terumo Cardiovascular is a division of Terumo Corporation, a leading medical device company operating in 160+ countries and regions RA'ANANA, Israel, Dec. 28, 2022 /PRNewswire/ -- Inspira Technologies...

Inspira™ Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report®
ORLANDO, Fla, Dec. 22, 2022 /PRNewswire/ -- RedChip Companies will air an interview with Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"),...

Inspira(TM) Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / December 22, 2022 / RedChip Companies will air a new interview with Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologie...

Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission
RA'ANANA, Israel, Dec. 20, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support tech...

Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
The agreement with Sheba Medical Center, 10th ranked hospital in the world*, to be the first site for the HYLA Blood Sensor's Clinical Study RA'ANANA, Israel , Dec. 14, 2022 /PRNewswire/ -- Inspira™ T...

Inspira™ Technologies Reports Third Quarter 2022 Financial Results
As of September 30, 2022, the Company had $16.2 million in cash, cash equivalents, and short-term bank deposits RA'ANANA, Israel , Nov. 23, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (N...

Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 for Deployment of 1,364 HYLA™ Blood Sensors
The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals RA'ANANA, Israel , Nov. 22, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASD...

InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System
RA'ANANA, Israel , Nov. 10, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support te...